Skip to content

Gimsilumab

Gimsilumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against granulocyte-macrophage colony-stimulating factor.
Trade Name
Common Name Gimsilumab
Indication
Drug Class Monoclonal antibodies: fully human, immunomodulating
Gimsilumab
Get full access now